Category
Olmesartan
CAS Number
Olmesartan medoxomil STD - 144689-63-4 ; IMP - A - 44689-24-7 ; IMP - B - 849206-43-5 ; IMP - C - 879562-26-2 ;
Molecular Formula
Olmesartan medoxomil STD - C29H30N6O6 ; IMP - A - C24H26N6O3 ; IMP - B - C24H24N6O2 ; IMP - C - C29H28N6O5 ;
Molecular Weight
Olmesartan medoxomil STD - 558.6 g/mol ; IMP - A - 446.5 g/mol ; IMP - B - 428.50 g/mol ; IMP - C - 540.6 g/mol ;
Synonym

Olmesartan medoxomil  STD -  (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate; 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester ;  

 Olmesartan medoxomil  EP Impurity  - A -  4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic acid ; Olmesartan Acid;1-((2`-(1H-tetrazol-5-yl)-[1,1`-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic Acid;1-([2`-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic Acid ; 

Olmesartan medoxomil  EP Impurity  - B - 6,6-Dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl]-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one ; 3-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6,6-dimethyl-2-propyl-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one; 3,6-Dihydro-6,6-dimethyl-2-propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Furo[3,4-d]imidazol-4-one; 1-{[2′-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one; 

Olmesartan medoxomil  EP Impurity - C -  (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(prop-1-en-2-yl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1Himidazole-5-carboxylate;(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate;

slide_1

Olmesartan medoxomil for system suitability CRS is used to confirm that chromatographic systems are performing properly by ensuring acceptable resolution, precision, and sensitivity. It also acts as a reference standard to verify the accuracy and reliability of analytical methods used to identify and quantify olmesartan medoxomil in pharmaceutical products.